Tamsulosin, the first prostate-selective α(1A)-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH)

European Urology

Volumn 29, Issue 2, 1996, Pages 145-154

  Schulman, C C ^a   Cortyriend, J ^a   Jonas, U ^a   Lock, T M T W ^a   Vaage, S ^a   Speakman, M J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

(1A) adrenergic receptor; 1 Adrenoceptor antagonists; Benign prostatic hyperplasia; Lower urinary tract symptoms; Receptor subtype; Tamsulosin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; TAMSULOSIN;

ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PULSE RATE; RETROGRADE EJACULATION; RHINITIS; SCORING SYSTEM; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINE FLOW RATE; VERTIGO; XEROSTOMIA;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; AGED; BLOOD PRESSURE; DOUBLE-BLIND METHOD; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SULFONAMIDES; URINATION;

EID: 0030069240     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)